Determination of autoantibodies to transglutaminase by electrochemiluminescence (ECL) assay

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Appearance of autoantibodies to tissue transglutaminase (TGA) is the most reliable biomarker to identify celiac disease autoimmunity. A nonradioactive assay of determination of TGA was newly developed using electrochemiluminescence (ECL) technology. This ECL assay has been demonstrated to be more sensitive than current standard radio-binding assay (RBA) in detecting TGA and can detect TGA earlier among high-risk young children followed from birth.

Cite

CITATION STYLE

APA

Zhao, Z., Gu, Y., Miao, D., Hoffmeyer, E., Liu, Y., & Yu, L. (2019). Determination of autoantibodies to transglutaminase by electrochemiluminescence (ECL) assay. In Methods in Molecular Biology (Vol. 1901, pp. 197–203). Humana Press Inc. https://doi.org/10.1007/978-1-4939-8949-2_16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free